An article1 in the September 2003 issue of the ARCHIVES reported on the use of a gel manufactured by Pacer Technology for purposes of “creating a temporary tarsorrhaphy in patients unsuitable for more invasive procedures, for temporary eyelid apposition for persistent epithelial defects, or just for ease of use in the office or at the bedside.”
Lindsay G. Misleading Information Given on Product Use. Arch Ophthalmol. 2005;123(1):126. doi:10.1001/archopht.123.1.126-b
Ophthalmology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.